EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY 4.0

SARS-CoV2-induced Schnitzler syndrome, inflammatory flare and successful treatment by anakinra during pregnancy: a case report

Louise Weible, Britta Maurer, Nicola Andina, Marc Daniel Gilgen

Swiss Medical Weekly · 2026

DOI: 10.57187/5590 ↗

At a glance

Fallbericht in Swiss Medical Weekly, 2026. Written by Louise Weible and 3 co-authors. Institution: Rheumatology and Immunology, Spitalzentrum Biel, Biel, Switzerland. Major MEDLINE topics: Schnitzler Syndrome, Interleukin 1 Receptor Antagonist Protein, Antirheumatic Agents, COVID-19. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

INTRODUCTION: Schnitzler syndrome is a rare acquired autoinflammatory disease characterised by a chronic urticarial rash, recurrent fever, arthralgia or arthritis, bone pain, elevated inflammatory markers, and monoclonal gammopathy. The disease is driven by dysregulated inflammasome activation and excessive interleukin-1 (IL-1) production. Because of its rarity, data on the management of Schnitzler syndrome during pregnancy remain extremely limited. We report the case of a pregnant woman presenting with a SARS-CoV-2-induced inflammatory flare that was successfully treated with anakinra, highlighting both the diagnostic and therapeutic challenges of this uncommon condition in pregnancy. CASE PRESENTATION: A pregnant woman in her early 40s with previously diagnosed Schnitzler syndrome presented with an acute inflammatory flare triggered by SARS-CoV-2 infection. Clinical manifestations included urticaria and musculoskeletal symptoms consistent with disease reactivation, along with elevated inflammatory markers. The diagnosis of Schnitzler syndrome had previously been established based on clinical criteria, supported by the presence of a chronic urticarial rash and monoclonal gammopathy in accordance with the Strasbourg and Lipsker diagnostic criteria. Due to the severity of the symptoms and the central role of IL-1 in disease pathophysiology, treatment with anakinra, an IL-1 receptor antagonist, was initiated. The patient experienced rapid clinical improvement, with resolution of systemic symptoms and normalisation of inflammatory parameters. Treatment was well tolerated, with favourable maternal and foetal outcomes throughout the pregnancy. CONCLUSION: This case highlights the importance of recognising Schnitzler syndrome as a rare but potentially severe autoinflammatory condition requiring prompt multidisciplinary management. It also suggests that anakinra may be a potential therapeutic option for inflammatory flares during pregnancy. Early recognition and targeted pharmacological treatment are essential to improving patient outcomes and preventing long-term complications.

Subjects

MeSH terms (MEDLINE)

Schnitzler SyndromeInterleukin 1 Receptor Antagonist ProteinAntirheumatic AgentsCOVID-19Pregnancy Complications, InfectiousPregnancy ComplicationsHumansFemalePregnancyAdultSARS-CoV-2UrticariaSymptom Flare Up

Substances

Interleukin 1 Receptor Antagonist ProteinAntirheumatic Agents

Authors and institutions

  • Rheumatology and Immunology, Spitalzentrum Biel, Biel, Switzerland.
  • Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.
  • Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital Bern, Bern, Switzerland.

Cite

APA

Weible, L., Maurer, B., Andina, N., & Gilgen, M. D. (2026). SARS-CoV2-induced Schnitzler syndrome, inflammatory flare and successful treatment by anakinra during pregnancy: a case report. Swiss Medical Weekly. https://doi.org/10.57187/5590

Vancouver

Weible L, Maurer B, Andina N, Gilgen MD. SARS-CoV2-induced Schnitzler syndrome, inflammatory flare and successful treatment by anakinra during pregnancy: a case report. Swiss Medical Weekly. 2026. doi:10.57187/5590

BibTeX
@article{Weible2026,
  author = {Weible, Louise and Maurer, Britta and Andina, Nicola and Gilgen, Marc Daniel},
  title = {SARS-CoV2-induced Schnitzler syndrome, inflammatory flare and successful treatment by anakinra during pregnancy: a case report},
  journal = {Swiss Medical Weekly},
  year = {2026},
  doi = {10.57187/5590}
}
Start for free →